Home › Funds › GENEVA CAPITAL MANAGEMENT LLC › AGYS
GENEVA CAPITAL MANAGEMENT LLC position in AGYS
AGILYSYS INC · Technology
GENEVA CAPITAL MANAGEMENT LLC reported holding 465,183 shares of AGYS (AGILYSYS INC) in its Q3 2026 13F filing — a position valued at US$45.2M, representing 1.26% of its reported portfolio and ranking #27 among its reported holdings. GENEVA CAPITAL MANAGEMENT LLC has disclosed AGYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GENEVA CAPITAL MANAGEMENT LLC's AGYS position evolved
GENEVA CAPITAL MANAGEMENT LLC first disclosed a stake in AGYS in Q3 2023 at 517,422 shares (US$34.2M). The position peaked in Q2 2025 at 816,637 shares, worth US$93.6M. Across 13 filings, GENEVA CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 465,183 shares valued at US$45.2M — a reduction of -67,812 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 517.42K | $34.23M | New |
| Q4 2023 | 620.36K | $52.62M | Add |
| Q1 2024 | 686.03K | $57.81M | Add |
| Q2 2024 | 672.70K | $70.05M | Reduce |
| Q3 2024 | 675.39K | $73.60M | Hold |
| Q4 2024 | 665.94K | $87.71M | Reduce |
| Q1 2025 | 765.36K | $55.52M | Add |
| Q2 2025 | 816.64K | $93.62M | Add |
| Q3 2025 | 817.80K | $86.07M | Hold |
| Q4 2025 | 732.02K | $86.99M | Reduce |
| Q1 2026 | 672.47K | $47.84M | Reduce |
| Q2 2026 | 533.00K | $55.70M | Reduce |
| Q3 2026 | 465.18K | $45.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AGYS and 13F data
AGYS (AGILYSYS INC) is a Technology company. 34 other funds we track also report a position in AGYS — the largest reported positions include MAK CAPITAL ONE LLC (US$124.6M), AltraVue Capital, LLC (US$53.5M), EMERALD ADVISERS, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AGYS
- MAK CAPITAL ONE LLC 1.19M sh · $124.64M · Q2 2026
- AltraVue Capital, LLC 550.77K sh · $53.47M · Q3 2026
- EMERALD ADVISERS, LLC 431.44K sh · $41.88M · Q3 2026
- Conestoga Capital Advisors, LLC 385.29K sh · $37.40M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 354.80K sh · $34.44M · Q3 2026
More on GENEVA CAPITAL MANAGEMENT LLC
FAQ
How long has GENEVA CAPITAL MANAGEMENT LLC held AGYS?
GENEVA CAPITAL MANAGEMENT LLC has disclosed AGYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GENEVA CAPITAL MANAGEMENT LLC's current position in AGYS?
As of Q3 2026, GENEVA CAPITAL MANAGEMENT LLC holds 465.18K shares of AGYS (AGILYSYS INC), valued at $45.16M, representing 1.26% of its reported portfolio and ranking #27.
Has GENEVA CAPITAL MANAGEMENT LLC been buying or selling AGYS?
In the latest 13F filing (Q3 2026), GENEVA CAPITAL MANAGEMENT LLC reduced its position in AGYS. The position peaked in Q2 2025 at 816.64K shares.
Which other funds hold AGYS?
Other major institutional holders of AGYS include MAK CAPITAL ONE LLC, AltraVue Capital, LLC, EMERALD ADVISERS, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.